Arrowhead Pharmaceuticals Inc News - ARWR | Aktien NASDAQ | ADVFN

Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Inc (ARWR) News

Arrowhead Pharmaceuticals Inc (ARWR)

16,97

-0,70

(-3,96%)

Geschlossen 09 März 9:00PM

Verzögert um 15 Minuten

16,86

-0,11

(-0,65%)

Nach Börsenschluss: 1:56AM

Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Form 424B7 - Prospectus [Rule 424(b)(7)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600

Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600 PR Newswire NEW YORK, Jan. 22, 2025 NEW...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Arrowhead Pharmaceuticals

Global X Russell 2000 Co...

VanEck Morningstar Wide ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen